RISANKIZUMAB-RZAA for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 40,890 adverse event reports in the FDA FAERS database where RISANKIZUMAB-RZAA was used for Psoriasis.
Most Reported Side Effects for RISANKIZUMAB-RZAA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Psoriasis | 6,896 | 10.5% | 12 | 778 |
| Drug ineffective | 2,885 | 4.4% | 6 | 379 |
| Pain | 2,584 | 4.0% | 18 | 571 |
| Fatigue | 2,483 | 3.8% | 4 | 446 |
| Arthralgia | 2,419 | 3.7% | 7 | 419 |
| Pruritus | 2,311 | 3.5% | 2 | 213 |
| Covid-19 | 2,145 | 3.3% | 55 | 640 |
| Death | 1,700 | 2.6% | 1,637 | 80 |
| Fall | 1,666 | 2.6% | 32 | 782 |
| Surgery | 1,662 | 2.5% | 5 | 245 |
| Headache | 1,554 | 2.4% | 5 | 239 |
| Diarrhoea | 1,427 | 2.2% | 7 | 475 |
| Crohn's disease | 1,338 | 2.1% | 12 | 685 |
| Device issue | 1,245 | 1.9% | 1 | 168 |
| Rash | 1,188 | 1.8% | 2 | 148 |
Other Indications for RISANKIZUMAB-RZAA
Crohn's disease (12,561)
Product used for unknown indication (7,604)
Psoriatic arthropathy (6,970)
Colitis ulcerative (786)
Rheumatoid arthritis (252)
Illness (79)
Hidradenitis (65)
Maternal exposure timing unspecified (65)
Guttate psoriasis (64)
Arthritis (57)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)
HUMIRA (6,346)